Treasurer of the State of North Carolina’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-37,530
Closed -$260K 1033
2023
Q1
$260K Buy
37,530
+3,660
+11% +$33.7K ﹤0.01% 1007
2022
Q4
$348K Buy
33,870
+430
+1% +$7.59K ﹤0.01% 1002
2022
Q3
$609K Buy
33,440
+430
+1% +$18.6K ﹤0.01% 995
2022
Q2
$1.7M Buy
33,010
+5,238
+19% +$271K 0.01% 865
2022
Q1
$2.04M Sell
27,772
-20,278
-42% -$1.81M 0.01% 797
2021
Q4
$6.88M Sell
48,050
-380
-0.8% -$65.3K 0.04% 437
2021
Q3
$10M Buy
48,430
+919
+2% +$203K 0.06% 317
2021
Q2
$10.1M Buy
47,511
+28,280
+147% +$5.18M 0.06% 307
2021
Q1
$3.49M Buy
+19,231
New +$3.83M 0.02% 603

Other funds holding NVAX

Treasurer of the State of North Carolina's NVAX Position: Q2 2023 in Review

Treasurer of the State of North Carolina sold out of Novavax (NVAX) in Q2 2023, closing a stake of 37,530 shares — an estimated $260K sold.

Treasurer of the State of North Carolina first reported a position in NVAX in Q1 2021 and held it in 9 quarters. The position peaked at $10.1M in Q2 2021. 216 funds tracked by Wall St. Rank hold NVAX as of Q2 2023.

  • Treasurer of the State of North Carolina reported no remaining Novavax position as of Q2 2023 after selling out during the quarter.
  • Treasurer of the State of North Carolina sold 37,530 Novavax shares in Q2 2023, an estimated $260K.
  • Treasurer of the State of North Carolina first reported a position in Novavax in Q1 2021 and held it in 9 quarters.
  • Treasurer of the State of North Carolina's Novavax position peaked at $10.1M in Q2 2021.
  • 216 funds tracked by Wall St. Rank held Novavax as of Q2 2023.

Based on Treasurer of the State of North Carolina's 13F filing for Q2 2023, filed 14 Aug 2023.